A team founded by TVGH and National Yang-Ming University (國立陽明大學) discovered that subanesthetic-dose ketamine works wonderfully on treatment-resistant depression. It can fill the time gap before any traditional anti-depression medication takes effect, which can be up to four weeks. The results of this study were released in Neuropsychopharmacology, a journal.